| CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ... The Journal of clinical investigation 121 (5), 1822-1826, 2011 | 1172 | 2011 |
| Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ... Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010 | 871 | 2010 |
| Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, ... Nature medicine 12 (10), 1160-1166, 2006 | 618 | 2006 |
| Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation AM Leen, CM Bollard, AM Mendizabal, EJ Shpall, P Szabolcs, JH Antin, ... Blood, The Journal of the American Society of Hematology 121 (26), 5113-5123, 2013 | 558 | 2013 |
| Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ... Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013 | 557 | 2013 |
| Cord-blood engraftment with ex vivo mesenchymal-cell coculture M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ... New England Journal of Medicine 367 (24), 2305-2315, 2012 | 512 | 2012 |
| Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, ... Journal of Clinical Oncology 32 (8), 798, 2014 | 496 | 2014 |
| Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease CM Bollard, L Aguilar, KC Straathof, B Gahn, MH Huls, A Rousseau, ... The Journal of experimental medicine 200 (12), 1623-1633, 2004 | 491 | 2004 |
| Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes KCM Straathof, CM Bollard, U Popat, MH Huls, T Lopez, MC Morriss, ... Blood 105 (5), 1898-1904, 2005 | 443 | 2005 |
| Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity CM Bollard, C Rössig, MJ Calonge, MH Huls, HJ Wagner, J Massague, ... Blood, The Journal of the American Society of Hematology 99 (9), 3179-3187, 2002 | 382 | 2002 |
| Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes CA Ramos, B Ballard, H Zhang, O Dakhova, AP Gee, Z Mei, M Bilgi, ... The Journal of clinical investigation 127 (9), 3462-3471, 2017 | 354 | 2017 |
| Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell … AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, ... Blood, The Journal of the American Society of Hematology 114 (19), 4283-4292, 2009 | 352 | 2009 |
| Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States JI Cohen, ES Jaffe, JK Dale, S Pittaluga, HE Heslop, CM Rooney, ... Blood, The Journal of the American Society of Hematology 117 (22), 5835-5849, 2011 | 340 | 2011 |
| Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer CM Bollard, S Gottschalk, AM Leen, H Weiss, KC Straathof, G Carrum, ... Blood, The Journal of the American Society of Hematology 110 (8), 2838-2845, 2007 | 338 | 2007 |
| International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) A Younes, P Hilden, B Coiffier, A Hagenbeek, G Salles, W Wilson, ... Annals of Oncology 28 (7), 1436-1447, 2017 | 320 | 2017 |
| T-cell therapy in the treatment of post-transplant lymphoproliferative disease CM Bollard, CM Rooney, HE Heslop Nature reviews Clinical oncology 9 (9), 510-519, 2012 | 289 | 2012 |
| Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral … PJ Hanley, CRY Cruz, B Savoldo, AM Leen, M Stanojevic, M Khalil, ... Blood, The Journal of the American Society of Hematology 114 (9), 1958-1967, 2009 | 282 | 2009 |
| Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma CU Louis, K Straathof, CM Bollard, S Ennamuri, C Gerken, TT Lopez, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (9), 983, 2010 | 262 | 2010 |
| Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy C Rossig, CM Bollard, JG Nuchtern, CM Rooney, MK Brenner Blood, The Journal of the American Society of Hematology 99 (6), 2009-2016, 2002 | 262 | 2002 |
| Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor AE Foster, G Dotti, A Lu, M Khalil, MK Brenner, HE Heslop, CM Rooney, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 31 (5), 500, 2008 | 240 | 2008 |
Helen HeslopCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and TexasVerified email at bcm.edu
